ALLAN JONATHAN (GENERAL COUNSEL & CORP SEC) sold 23.6% of their position (8.89K shares) of STOKE THERAPEUTICS, INC. on the open market
Open‑market sale worth $285.9K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 5 sales
Filed: 3/19/2026ACC: 0001966716-26-000006
Officer· GENERAL COUNSEL & CORP SEC
Since Feb 2026
-8.89K
Net shares
Net seller
$285.9K
Total sold
5
Open market trades
0B · 5S
5
Total transactions
8.89K disposed
Non-Derivative Transactions5
Common Stock
Direct
Shares
−2.48K
Price / share
$32.74
Trade value
$81.06K
% of position
6.6%
3/17/2026
37.73K→35.26K
Common Stock
Direct
Shares
−1.79K
Price / share
$33.38
Trade value
$59.78K
% of position
5.1%
3/17/2026
35.26K→33.46K
Common Stock
Direct
Shares
−4.22K
Price / share
$31.28
Trade value
$132.08K
% of position
12.6%
3/18/2026
33.46K→29.24K
Common Stock
Direct
Shares
−334.00
Price / share
$31.79
Trade value
$10.62K
% of position
1.1%
3/18/2026
29.24K→28.91K
Common Stock
Direct
Shares
−72.00
Price / share
$32.85
Trade value
$2.37K
% of position
0.2%
3/18/2026
28.91K→28.84K
Total
Net shares
−8.89K
Net value
-$285.90K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/17/2026 | S · Sale | −2.48K | $32.74 | $81.06K | 6.6% | 37.73K | 35.26K |
| Common Stock Direct | 3/17/2026 | S · Sale | −1.79K | $33.38 | $59.78K | 5.1% | 35.26K | 33.46K |
| Common Stock Direct | 3/18/2026 | S · Sale | −4.22K | $31.28 | $132.08K | 12.6% | 33.46K | 29.24K |
| Common Stock Direct | 3/18/2026 | S · Sale | −334.00 | $31.79 | $10.62K | 1.1% | 29.24K | 28.91K |
| Common Stock Direct | 3/18/2026 | S · Sale | −72.00 | $32.85 | $2.37K | 0.2% | 28.91K | 28.84K |
| Total | −8.89K | -$285.90K | ||||||
Derivative Transactions0
No derivative transactions reported